Satellos Bioscience Inc. (TSX: MSCL)
Health Care · Biotechnology · CA
CA$10.71
-10.82% today · +14.4% 1Y
Satellos Bioscience Inc. (TSX: MSCL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $159.25M and employs 18 people.
Over the last twelve months the share price has gained 14.4%, trading between 7.56 and 18.98.
Tweenvest scores Satellos Bioscience Inc. across four factors: quality 35/100, value 58/100. Its strongest factor is value.
MSCL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $159.25M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.99
- Dividend yield
- —
- Beta (5Y)
- 1.14
- 52-week high
- CA$18.98
- 52-week low
- CA$7.56
- Avg volume (3M)
- —
- Shares outstanding
- 21.22M
- Employees
- 18
- Next earnings
- —
About Satellos Bioscience Inc.
Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
- ISIN
- CA80401L8033
- Founded
- 2018
- Listed since
- Jan 7, 2008
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NovaBridge BiosciencesNasdaqGM: NBP | $161.82M | $1.40 | +1.82% |
| Nkarta, Inc.NasdaqGS: NKTX | $161.16M | $2.25 | -12.62% |
| curacle co.,ltd.KOSDAQ: A365270 | $161.02M | ₩9,770.00 | -4.22% |
| Pacific Edge LimitedNZSE: PEB | $160.23M | NZ$0.23 | -8.00% |
| Jyong Biotech Ltd.NasdaqGM: MENS | $155.89M | $2.10 | -3.67% |
| BNC KOREA, Inc.KOSDAQ: A256840 | $155.68M | ₩3,060.00 | -3.01% |
| Helixmith Co., LtdKOSDAQ: A084990 | $155.16M | ₩4,530.00 | +22.60% |
| Innovacell Inc.TSE: 504A | $155.13M | ¥544.00 | -9.63% |
Figures last refreshed Oct 11, 2026.